Scott Nolan

I don't know.

Like maybe if it doesn't look like a good idea, I wouldn't do it.

But I think for many of these patients today that are paralyzed or ALS or blind or deaf or, you know, missing limbs, how can we actually like use the Neuralink type device to let them get full capability back?

That's what excites me about Neuralink.

So yeah, we've had a chance to be a bunch of, to be a part of many cool companies.

Even some that are more conventional, like a friend of ours at Founders Fund started a company for cancer therapeutics.

So specifically dealing with types of cancer and really looking for the target on the cancer that they could go after.

And they ended up selling that company and now the same target that they were working on is now showing up in a bunch of drugs.

from that company that they sold to and then other companies so it's yeah a lot of this stuff is really futuristic and feels more distant but then also getting to back unconventional approaches in things like cancer therapeutics and watching patients eventually get cured from that wow it's been really cool i'll bet i'll bet what are you guys focusing on now

I'd say the Founders Fund thing is it's always seemingly a black box from the outside.

It's seemingly random.

And so, you know, one saying is that once there's a theme of what we're doing or like there's a category that you can be a part of, it's already something Founders Fund probably won't invest in.

It's probably already too late.

So people talk about commercial space now and all the things happening in space, but the Founders Fund first investment in SpaceX was 2008.

And so...

In terms of what categories are we investing in now, it's really the anti-category that it always has been.

It's always been, what's the thing that's coming but isn't yet obvious?

And that's not something that the Founders Fund team is so smart that they can figure out.

It's that the founders bring those ideas to Founders Fund.

The founders of these companies say, hey, this is the important problem no one is solving.